24 July 2024
TruSpine Technologies
plc
("TruSpine"
or the "Company")
Convertible Loan Note
Extension & Related Party Transaction
TruSpine Technologies Plc, the
medical device company focused on the spinal (vertebral)
stabilisation market, that further to the announcement on 28 March
2024, the Company has extended the maturity date of the convertible
loan note ("CLN") to 30 June 2025. All other terms of the CLN
remain unchanged.
Related Party Transaction
The extension of maturity date of
the CLN (the "Transaction") is a related party transaction for the
purposes of Rule 4.6 of the AQSE Growth Market Access Rulebook, by
virtue of the Company and Geoff Miller, Non-executive Chairman of
the Company, being a party to the CLN. The directors of TruSpine
independent of the Transaction confirm that, having exercised
reasonable care, skill and diligence, the Transaction is fair and
reasonable insofar as the shareholders of TruSpine are
concerned.
This announcement contains inside
information for the purposes of the UK Market Abuse
Regulation and the Directors of the Company are responsible for the
release of this announcement.
-END-
|
TruSpine Investor Hub
|
https://investorhub.truspinetech.com
|
|
TruSpine Technologies Plc
|
Tel: +44 (0)20 7118 0852
|
|
Geoff Miller, Non-executive
Chairman
|
|
|
|
|
|
Cairn
Financial Advisers LLP (AQSE Corporate Adviser)
|
Tel: +44
(0)20 7213 0880
|
|
Liam Murray / Ludovico
Lazzaretti
|
|
|
Peterhouse Capital Limited (Broker & Financial
Adviser)
|
Tel: +44 (0)20 7469 0930
|
|
Lucy Williams / Duncan
Vasey
|
|
|
Novus
Communications (PR and IR)
|
Tel: +44
(0)1273 704 473
|
|
Alan Green / Jacqueline
Briscoe
|
J.Briscoe@novuscomms.com
|
Caution regarding forward looking statements
Certain statements in this
announcement, are, or may be deemed to be, forward looking
statements. Forward looking statements are identified by their use
of terms and phrases such as ''believe'', ''could'', "should"
''envisage'', ''estimate'', ''intend'', ''may'', ''plan'',
''potentially'', "expect", ''will'' or the negative of those,
variations or comparable expressions, including references to
assumptions. These forward-looking statements are not based on
historical facts but rather on the Directors' current expectations
and assumptions regarding the Company's future growth, results of
operations, performance, future capital and other expenditures
(including the amount, nature and sources of funding thereof),
competitive advantages, business prospects and opportunities. Such
forward looking statements reflect the Directors' current beliefs
and assumptions and are based on information currently available to
the Directors.